Aprea Therapeutics Inc.

12/11/2024 | Press release | Distributed by Public on 12/11/2024 07:36

Aprea Therapeutics Announces Twice Daily (BID) Dosing of Patients in ABOYA 119 Clinical Trial of ATRN 119 to Potentially Optimize Clinical Outcomes and Strengthen Clinical Path[...]